Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Amarantus Bioscience Holdi AMBS
Posted On: 07/17/2014 11:49:56 AM
Post# of 30067
Posted By: Daveludlow
Re: seebisquick #2059
The "bridge test" comparing version 1 & 2 of LymPro is different from the "Analytical Performance Test" BD performed in Q2 2014 with about 160 patients. I know for sure that "Analytical" test contains "sensitivity" and "specificity" data. That is what we have all been waiting for.

The "bridge test" is extra! It too may contain the two "s" numbers. They may even be better since this test is comparing versions 1 verses 2 of LymPro. We will get some "top line" info on that test on the 31st, but I don't think that test will be complete. I think "top line" means a brief update on what they can report by then.

But it is the Beckton Dickenson "analytical performance" data that we are all waiting for. And that will be presented on the 31st. Most of us assumed it would be presented in Copenhagen, but it was delayed for whatever reason.













(0)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site